About Oc Specialities
Data last updated:
Oc Specialities is a company based in Mumbai (India) founded in 2005. It operates as a B2B. The company has 51 employees. Oc Specialities operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
- Annual Revenue$39.4 M (USD)0as on Mar 31, 2024
- Employee Count51
Associated legal entities of Oc Specialities
Oc Specialities is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity, and a full company report can be bought for any of them.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Report |
|---|---|---|---|---|---|---|---|
| Oc Specialities Chemicals Private Limited CIN U24100MH2019PTC325214 | Active | 09 May 2019 | Mumbai, Maharashtra | ₹525 Cr | 31 | 3 | Buy report |
| Oc Specialities Private Limited CIN U24100MH2005PTC150735 | Active | 19 Jan 2005 | Mumbai, Maharashtra | ₹283 Cr | 354 | 3 | Buy report |
Board of directors of Oc Specialities
The boards of the 2 registered companies of Oc Specialities currently have 3 directors; the longest-serving is Vikas Mangilal Shah, appointed in 2005. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vikas Mangilal Shah DIN 00036542 | Director | 19 Jan 2005 | 21 yrs 8 mo | Oc Specialities Private Limited, Oc Specialities Chemicals Private Limited |
| Manish Shah Mangilal DIN 00036482 | Managing Director | 19 Jan 2005 | 21 yrs 8 mo | Oc Specialities Private Limited, Oc Specialities Chemicals Private Limited |
| Pushpak Mangilal Shah DIN 00036507 | Director | 19 Jan 2005 | 21 yrs 8 mo | Oc Specialities Private Limited, Oc Specialities Chemicals Private Limited |
Financials of Oc Specialities
Figures of Oc Specialities Private Limited, the primary company behind Oc Specialities, for FY 2025. Revenue was ₹283 Cr (-14% year on year). Net loss was -₹0.35 Cr (0% margin). EBITDA was ₹41.70 Cr (15% margin). Revenue has grown at a compounded annual rate of -11% over five years.
- ₹283 CrRevenue · FY 2025 · -14% YoY
- -₹0.35 CrNet loss · 0% margin
- ₹41.70 CrEBITDA · 15% margin
- ₹0.04 CrPaid-up capital
- 354Employees (provident fund records)
- -11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Oc Specialities Private Limited are on its company page.
Buy the company report of Oc Specialities Private LimitedDetailed financial statements for Oc Specialities
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Oc Specialities
Oc Specialities operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pharmaron.com | 2003 | Beijing, China | $320.0M | 476 | Drug discovery and development services for small molecules are provided. | |
| lonza.com | 1897 | Basel, Switzerland | $100,000 | 14,500 | CDMO services for pharma, biotech, and specialty ingredients are provided. | |
| pfizer.com | 1849 | New York, United States | $8.0M | – | Pharmaceutical products for treating multiple diseases are provided. | |
| boehringer-ingelheim.com | 1885 | – | – | 31 | Generic drugs and clinical research services are provided globally. | |
| labconnect.com | 2002 | Johnson, United States | $28.5M | – | Laboratory testing, clinical trial research, and biopharma services are provided. | |
| dotmatics.com | 2005 | – | $11.3M | 512 | AI powered scientific data management and workflow automation solutions | |
| ainos.com | 1986 | San Diego, United States | – | 43 | Novel point-of-care testing and low-dose interferon therapeutics are developed. | |
| biomatter.ai | 2018 | Vilnius, Lithuania | $7.7M | – | Provider of synthetic biology and AI-based technology for generative protein design | |
| betadrugslimited.com | 2005 | Panchkula, India | – | 637 | Developer of therapeutics for oncology and dermatology |
Detailed competitors of Oc Specialities
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Oc Specialities
Oc Specialities was founded in 2005.
Oc Specialities is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Oc Specialities has 51 employees.
Annual revenue of Oc Specialities is $39.4M as on Mar 31, 2024.
Oc Specialities a cdmo specializing in pharmaceutical product manufacturing and research services through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and cdmo services. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Oc Specialities is associated with 2 legal entities: Oc Specialities Chemicals Private Limited, Oc Specialities Private Limited.
The legal entities of Oc Specialities currently have 3 directors, including Vikas Mangilal Shah, Manish Shah Mangilal, Pushpak Mangilal Shah.